BRISTOL MYERS SQUIBB CO (BMY)
Data as of , from SEC Form 4 filings.
See up to 3 months of BMY. The 7-day demo opens the 1M and 3M ranges and puts BMY on your watchlist.
Start 7-day demoLatest BMY insider trades
About BRISTOL MYERS SQUIBB CO (BMY)
BRISTOL MYERS SQUIBB CO is an SEC registrant, filing under CIK 0000014272, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
BMY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 6,749 | $437K |
| Grant or award | 5 | 3,125 | |
| Option exercise | 8 | 116,056 | |
BMY insider transactions (Form 4)
3887 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Derica W. Rice - Director | Grant or award | Deferred Share Units | 831.49 | $0.00 | - | |
| Peter J. Arduini - Director | Grant or award | Deferred Share Units | 748.34 | $0.00 | - | |
| Grant or award | Deferred Share Units | 776.05 | $0.00 | - | ||
| Open-market sale | Common Stock, $0.10 par value | 56,000 | $47.33 | $2.65M | ||
| Bartie Wendy Short - Officer | Option exercise | Common Stock, $0.10 par value | 1,235 | $0.00 | - | |
| Bartie Wendy Short - Officer | Tax withholding / forfeiture | Common Stock, $0.10 par value | 632 | $47.18 | $30K | |
| Bartie Wendy Short - Officer | Option exercise | Restricted Stock Units | 1,235 | $0.00 | - | |
| Bartie Wendy Short - Officer | Option exercise | Common Stock, $0.10 par value | 738 | $0.00 | - | |
| Bartie Wendy Short - Officer | Open-market sale | Common Stock, $0.10 par value | 378 | $44.23 | $17K | |
| Bartie Wendy Short - Officer | Option exercise | Restricted Stock Units | 738 | $0.00 | - | |
| Cari Gallman - Officer | Option exercise | Common Stock, $0.10 par value | 1,061 | $0.00 | - | |
| Cari Gallman - Officer | Tax withholding / forfeiture | Common Stock, $0.10 par value | 543 | $44.23 | $24K | |
| Cari Gallman - Officer | Option exercise | Restricted Stock Units | 1,061 | $0.00 | - | |
| Cristian Massacesi - Officer | Grant or award | Restricted Stock Units | 204,691 | $0.00 | - | |
| Grant or award | Restricted Stock Units | 12,810 | $0.00 | - | ||
| Grant or award | Deferred Share Units | 1,080 | $0.00 | - | ||
| Grant or award | Deferred Share Units | 728.36 | $0.00 | - | ||
| Derica W. Rice - Director | Grant or award | Deferred Share Units | 810.11 | $0.00 | - | |
| Peter J. Arduini - Director | Grant or award | Deferred Share Units | 729.1 | $0.00 | - | |
| Grant or award | Deferred Share Units | 756.1 | $0.00 | - | ||
| Grant or award | Deferred Share Units | 573.87 | $60.99 | $35K | ||
| Samit Hirawat - Officer | Open-market purchase | Common Stock, $0.10 par value | 1,830 | $54.68 | $100K | |
| Phil M. Holzer - Officer | Open-market sale | Common Stock, $0.10 par value | 700 | $55.62 | $39K | |
| Karin Shanahan - Officer | Grant or award | Restricted Stock Units | 18,843 | $0.00 | - | |
| Gregory Scott Meyers - Officer | Grant or award | Restricted Stock Units | 18,843 | $0.00 | - | |
| Christopher S. Boerner - Officer | Option exercise | Common Stock, $0.10 par value | 2,964 | $0.00 | - | |
| Christopher S. Boerner - Officer | Other | Common Stock, $0.10 par value | 55 | $0.00 | - | |
| Christopher S. Boerner - Officer | Tax withholding / forfeiture | Common Stock, $0.10 par value | 1,488 | $54.32 | $81K | |
| Christopher S. Boerner - Officer | Option exercise | Market Share Units | 2,964 | $0.00 | - | |
| Cari Gallman - Officer | Option exercise | Common Stock, $0.10 par value | 4,558 | $0.00 | - | |
| Cari Gallman - Officer | Tax withholding / forfeiture | Common Stock, $0.10 par value | 1,648 | $53.76 | $89K | |
| Cari Gallman - Officer | Option exercise | Restricted Stock Units | 4,558 | $0.00 | - | |
| Grant or award | Deferred Share Units | 966.37 | $51.74 | $50K | ||
| Deepak Bhatt - Director | Grant or award | Deferred Share Units | 169.12 | $51.74 | $9K | |
| Grant or award | Deferred Share Units | 603.98 | $51.74 | $31K | ||
| Derica W. Rice - Director | Grant or award | Deferred Share Units | 724.78 | $51.74 | $38K | |
| Peter J. Arduini - Director | Grant or award | Deferred Share Units | 652.3 | $51.74 | $34K | |
| Grant or award | Deferred Share Units | 676.46 | $51.74 | $35K |
Recent BMY Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Massacesi Cristian | Officer | 6,249 | $403K | View on EDGAR | |
| Holzer Phil M | Officer | 500 | $34K |
Stock trades in BMY disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
BMY insider trading FAQ
What is the latest insider trade for BMY?
BRISTOL MYERS SQUIBB CO (BMY) had 11 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for BMY runs to 87 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BMY stock?
No insider purchases of BMY were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling BMY stock?
2 insider sales of BMY were filed in the last 90 days, totaling $437K.
Where can I see BMY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BMY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Cari Gallman view on EDGAR
- - Phyllis R. Yale view on EDGAR
- - Theodore R. Samuels II view on EDGAR
- - Derica W. Rice view on EDGAR
- - Michael R. McMullen view on EDGAR
- - Peter J. Arduini view on EDGAR
- - Cristian Massacesi view on EDGAR
- - Bartie Wendy Short view on EDGAR
- - Phil M. Holzer view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BMY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BMY with a 7-day demo
- BMY on your watchlist
- Every BMY Form 4 filing on record
- Up to 3 months of BMY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive